309 related articles for article (PubMed ID: 28004354)
1. Systematic Investigation of Expression of G2/M Transition Genes Reveals CDC25 Alteration in Nonfunctioning Pituitary Adenomas.
Butz H; Németh K; Czenke D; Likó I; Czirják S; Zivkovic V; Baghy K; Korbonits M; Kovalszky I; Igaz P; Rácz K; Patócs A
Pathol Oncol Res; 2017 Jul; 23(3):633-641. PubMed ID: 28004354
[TBL] [Abstract][Full Text] [Related]
2. KCTD12 promotes tumorigenesis by facilitating CDC25B/CDK1/Aurora A-dependent G2/M transition.
Zhong Y; Yang J; Xu WW; Wang Y; Zheng CC; Li B; He QY
Oncogene; 2017 Nov; 36(44):6177-6189. PubMed ID: 28869606
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of Wee1 kinase by a specific subset of microRNA in human sporadic pituitary adenomas.
Butz H; Likó I; Czirják S; Igaz P; Khan MM; Zivkovic V; Bálint K; Korbonits M; Rácz K; Patócs A
J Clin Endocrinol Metab; 2010 Oct; 95(10):E181-91. PubMed ID: 20668041
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA profile indicates downregulation of the TGFβ pathway in sporadic non-functioning pituitary adenomas.
Butz H; Likó I; Czirják S; Igaz P; Korbonits M; Rácz K; Patócs A
Pituitary; 2011 Jun; 14(2):112-24. PubMed ID: 21063788
[TBL] [Abstract][Full Text] [Related]
5. Cdc25 phosphatases are required for timely assembly of CDK1-cyclin B at the G2/M transition.
Timofeev O; Cizmecioglu O; Settele F; Kempf T; Hoffmann I
J Biol Chem; 2010 May; 285(22):16978-90. PubMed ID: 20360007
[TBL] [Abstract][Full Text] [Related]
6. HOXB13 contributes to G1/S and G2/M checkpoint controls in prostate.
Hamid SM; Cicek S; Karamil S; Ozturk MB; Debelec-Butuner B; Erbaykent-Tepedelen B; Varisli L; Gonen-Korkmaz C; Yorukoglu K; Korkmaz KS
Mol Cell Endocrinol; 2014 Mar; 383(1-2):38-47. PubMed ID: 24325868
[TBL] [Abstract][Full Text] [Related]
7. circOMA1-Mediated miR-145-5p Suppresses Tumor Growth of Nonfunctioning Pituitary Adenomas by Targeting TPT1.
Du Q; Hu B; Feng Y; Wang Z; Wang X; Zhu D; Zhu Y; Jiang X; Wang H
J Clin Endocrinol Metab; 2019 Jun; 104(6):2419-2434. PubMed ID: 30721952
[TBL] [Abstract][Full Text] [Related]
8. MicroRNAs expression in pituitary tumors: differences related to functional status, pathological features, and clinical behavior.
Vicchio TM; Aliquò F; Ruggeri RM; Ragonese M; Giuffrida G; Cotta OR; Spagnolo F; Torre ML; Alibrandi A; Asmundo A; Angileri FF; Esposito F; Polito F; Oteri R; Aguennouz MH; Cannavò S; Ferraù F
J Endocrinol Invest; 2020 Jul; 43(7):947-958. PubMed ID: 31939196
[TBL] [Abstract][Full Text] [Related]
9. Next-generation sequencing of microRNAs reveals a unique expression pattern in different types of pituitary adenomas.
He Z; Chen L; Hu X; Tang J; He L; Hu J; Fei F; Wang Q
Endocr J; 2019 Aug; 66(8):709-722. PubMed ID: 31061247
[TBL] [Abstract][Full Text] [Related]
10. PP2A inhibitors arrest G2/M transition through JNK/Sp1- dependent down-regulation of CDK1 and autophagy-dependent up-regulation of p21.
Gong FR; Wu MY; Shen M; Zhi Q; Xu ZK; Wang R; Wang WJ; Zong Y; Li ZL; Wu Y; Zhou BP; Chen K; Tao M; Li W
Oncotarget; 2015 Jul; 6(21):18469-83. PubMed ID: 26053095
[TBL] [Abstract][Full Text] [Related]
11. TIAR marks nuclear G2/M transition granules and restricts CDK1 activity under replication stress.
Lafarga V; Sung HM; Haneke K; Roessig L; Pauleau AL; Bruer M; Rodriguez-Acebes S; Lopez-Contreras AJ; Gruss OJ; Erhardt S; Mendez J; Fernandez-Capetillo O; Stoecklin G
EMBO Rep; 2019 Jan; 20(1):. PubMed ID: 30538118
[TBL] [Abstract][Full Text] [Related]
12. Identification of differentially expressed microRNAs by microarray: a possible role for microRNA genes in pituitary adenomas.
Bottoni A; Zatelli MC; Ferracin M; Tagliati F; Piccin D; Vignali C; Calin GA; Negrini M; Croce CM; Degli Uberti EC
J Cell Physiol; 2007 Feb; 210(2):370-7. PubMed ID: 17111382
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of CDC25A and CDC25B in head and neck cancers.
Gasparotto D; Maestro R; Piccinin S; Vukosavljevic T; Barzan L; Sulfaro S; Boiocchi M
Cancer Res; 1997 Jun; 57(12):2366-8. PubMed ID: 9192810
[TBL] [Abstract][Full Text] [Related]
14. Serine-Threonine Kinase 38 regulates CDC25A stability and the DNA damage-induced G2/M checkpoint.
Fukasawa T; Enomoto A; Miyagawa K
Cell Signal; 2015 Aug; 27(8):1569-75. PubMed ID: 25936524
[TBL] [Abstract][Full Text] [Related]
15. Mir-23b and miR-130b expression is downregulated in pituitary adenomas.
Leone V; Langella C; D'Angelo D; Mussnich P; Wierinckx A; Terracciano L; Raverot G; Lachuer J; Rotondi S; Jaffrain-Rea ML; Trouillas J; Fusco A
Mol Cell Endocrinol; 2014 Jun; 390(1-2):1-7. PubMed ID: 24681352
[TBL] [Abstract][Full Text] [Related]
16. Diosbulbin B induced G
Yang R; Wei M; Yang F; Sheng Y; Ji L
Toxicol Appl Pharmacol; 2018 Oct; 357():1-9. PubMed ID: 30145177
[TBL] [Abstract][Full Text] [Related]
17. Somatotropinomas, but not nonfunctioning pituitary adenomas, maintain a functional apoptotic RET/Pit1/ARF/p53 pathway that is blocked by excess GDNF.
Diaz-Rodriguez E; Garcia-Rendueles AR; Ibáñez-Costa A; Gutierrez-Pascual E; Garcia-Lavandeira M; Leal A; Japon MA; Soto A; Venegas E; Tinahones FJ; Garcia-Arnes JA; Benito P; Angeles Galvez M; Jimenez-Reina L; Bernabeu I; Dieguez C; Luque RM; Castaño JP; Alvarez CV
Endocrinology; 2014 Nov; 155(11):4329-40. PubMed ID: 25137025
[TBL] [Abstract][Full Text] [Related]
18. Aberrant expression of the sFRP and WIF1 genes in invasive non-functioning pituitary adenomas.
Song W; Qian L; Jing G; Jie F; Xiaosong S; Chunhui L; Yangfang L; Guilin L; Gao H; Yazhuo Z
Mol Cell Endocrinol; 2018 Oct; 474():168-175. PubMed ID: 29555596
[TBL] [Abstract][Full Text] [Related]
19. Novel Biomarkers for Non-functioning Invasive Pituitary Adenomas were Identified by Using Analysis of microRNAs Expression Profile.
Wu S; Gu Y; Huang Y; Wong TC; Ding H; Liu T; Zhang Y; Zhang X
Biochem Genet; 2017 Jun; 55(3):253-267. PubMed ID: 28315020
[TBL] [Abstract][Full Text] [Related]
20. Altered microRNA expression profile in human pituitary GH adenomas: down-regulation of miRNA targeting HMGA1, HMGA2, and E2F1.
D'Angelo D; Palmieri D; Mussnich P; Roche M; Wierinckx A; Raverot G; Fedele M; Croce CM; Trouillas J; Fusco A
J Clin Endocrinol Metab; 2012 Jul; 97(7):E1128-38. PubMed ID: 22564666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]